What is going on in the wide and wacky world of pain and fatigue? What use to be called fibromyalgia is being reclassified as myalgic encephalomyelitis (ME/CFS) or systemic exertion intolerance disease. Although fibromyalgia has many faces, it does not deserve many names.
Fatigue is not far behind pain as the complaint that affects the quality of life in numerous rheumatic and autoimmune disorders. But do we need to focus on fatigue in our disease management?
There are no detailed recommendations agreed upon by SLE experts on what treatment to use after first and second (and often third) line treatment has failed.
If you’re going to spend 10-20% of your clinic hours examining and caring for 28 or 68 or 360 joints – it may be instructive to own up to those joints we excel at and take note of the ones we avoid, despise or struggle with.
I was recently asked, “what is the best kind of arthritis to have?” My response is based on diagnosibility, treatability and safety of necessary treatment.
In 2012, a Medscape survey of US physicians revealed rheumatology as the most satisfying of medical specialties. This came as a surprise to many as rheumatologists see themselves as the Rodney Dangerfields of medical specialists.
Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?
While the FRAX is useful to determine if individuals with low bone mass may benefit from treatment for osteoporosis, this method also has some shortcomings.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
